Does RA Begin in the Gut? Dr. Jonathan Kay
Comparative Effectiveness: Registries or Real Life? Dr. Jonathan Kay
Did I Forget Something? Dr. Jonathan Kay
Dr. Jonathan Kay on Dominant B Cell Receptor Clones at ACR 2018
Dr. Jonathan Kay with more on The Great Debate of ACR 2018
A Triple Header of RA Plenary Abstracts: Dr. Jonathan Kay
Dr. Jonathan Kay on Biosimilars at ACR 2018
Dr. Jonathan Kay - Best Thing I Saw Today on RA - Vagus Nerve Stimulation
ABCs of RA: Panel Discussion with Dr. Jonathan Kay
The Risk RA Prospective Study: Dr. Jonathan Kay
The Lungs: The Alpha and Omega of RA with Dr. Jonathan Kay
Potpourri of Biosimilar Trials: Dr. Jonathan Kay
Rheumatoid Arthritis and Cancer: Myth or Reality? Dr. Jonathan Kay
Might Tofacitinib Reduce Malignancy Risk with Patients with RA? Dr. Jonathan Kay
Does Hydroxychloroquine Hurt the Heart? Dr. Jonathan Kay
Dr. Jonathan Kay: Subcutaneous Biosimilar
MACE + VTE Across Upadacitinib Studies in RA Patients: Dr. Jonathan Kay
Potpourri of Pathotypes of Predictors with Dr. Jonathan Kay and colleagues
Cardiovascular Risk on MTX in Rheumatoid Arthritis: Dr. Jonathan Kay
Dr. Jonathan Kay - Biosimilars at EULAR 2016